Breast cancer in the elderly

01 October 2021

02 October 2021

Co-Chairs: L. Biganzoli, IT - O.Pagani, CH

Breast cancer management in older patients can be challenging and requires calibrated and weighted risk-benefit decision making. Despite breast cancer being a common disease in older women, few evidence-based recommendations exist upon which oncologists can ground their clinical decisions. The course will handle breast cancer management in older patients from different perspectives, from the place older people have in our society to the characterization and needs of older patients according to different health professional specialties including patients’ advocates.

Specific diagnostic and treatment scenarios and controverses will be discussed and debated emphasizing the most relevant pending questions and new evidence. The overall aim is to provide a broad panorama on how to address the complexity of different disease settings in older patients and to help clinicians to understand and select the best available choices in routine clinical practice, when sitting in a multidisciplinary meeting or in front of the patient according.
Laura Biganzoli and Olivia Pagani

INFORMATION

Registration for the course is mandatory but free.

During the live streaming of the event (1/2 October 2021) live and pre-recorded sessions will be webcasted and participants will be able to discuss the topics with the involved experts via chat.

All the content will be recorded and will remain accessible via the e-ESO website UNTIL OCTOBER 2022 (registration to access the contents will remain open).

CONFIRMATION OF REGISTRATION

Registration will be confirmed by e-mail.

ORGANISING SECRETARIAT

Mariachiara Deleo - mdeleo@eso.net

Sarah Goldman - sgoldman@eso.net
Dolores Knupfer - dknupfer@eso.net
Francesca Marangoni - fmarangoni@eso.net

CME ACCREDITATION CERTIFICATES

Participants will be issued a certificate of attendance (minimum attendance: 75% of the entire course). An online evaluation questionnaire and learning assessment test will need to be completed in order to get the certificate that will be issued by email.
Application for CME recognition has been submitted to the Accreditation Council of Oncology in Europe (ACOE) and 5 CME credits have been granted to this event. The American Medical Association (AMA) and the Accreditation Council for Continuous Medical Education (ACCME) designate this type of educational activity for a maximum of 1 AMA PRA category 1 credits per hour of activity.
CME credits will be available until 2 October 2022.

ESCO CREDITS

The course enables ESCO students to earn ESCO credits and therefore access more ESCO benefits. Full and active participation in the course earns participants 5 ESCO credits.

Visit www.esco.org for information on how to join ESCO.

Social media

Use the hashtag #ESOexperience and follow us on Facebook, Twitter and Instagram: @esoncology

Instructions on how to use e-ESO to participate in this event

The course will remain available until OCTOBER 2022.

PART 1 – THE LANDSCAPE OF THE ELDERLY PATIENT

01/10/2021

Welcome and introduction

Chairs:

Laura Biganzoli, IT - Olivia Pagani, CH

The value of being older

Expert:

Susan Knox, IT

Who is the older adult patient?

A geriatrician's point of view

Expert:

Giuseppe Colloca, IT

An oncologist's point of view

Expert:

Alexandru Eniu, CH

An onco-geriatrician's point of view

Expert:

Hans Wildiers, BE

Needs and expectations of elderly breast cancer patients

A nurse's experience

Expert:

Wendy Oldenmenger, NL

A psycho-oncologist's experience – early and advanced cancer

Expert:

Luzia Travado, PT

A geriatrician's experience

Expert:

Juliet Wright, UK

A patient advocate's experience

Expert:

Elizabeth Bergsten Nordström, SE

Q&A

Experts:	Elizabeth Bergsten Nordström, SE - Giuseppe Colloca, IT - Alexandru Eniu, CH - Susan Knox, IT - Wendy Oldenmenger, NL - Luzia Travado, PT - Hans Wildiers, BE - Juliet Wright, UK
Chairs:	Laura Biganzoli, IT - Olivia Pagani, CH

PART 2 – DEBATE: Is breast screening in patients over 70 cost effective?

02/10/2021

Moderator:

Olivia Pagani, CH

YES

Expert:

Nicolien T. van Ravesteyn, NL

Expert:

Pietro Panizza, IT

Q&A

Experts:	Pietro Panizza, IT - Nicolien T. van Ravesteyn, NL
Moderator:	Olivia Pagani, CH

PART 3 – DIAGNOSIS AND TREATMENT

02/10/2021

Introduction

Chairs:

Laura Biganzoli, IT - Olivia Pagani, CH

Can we adapt the standard according to patient’s health status?

Surgery

Expert:

Riccardo A. Audisio, IT

Radiotherapy

Expert:

Ian Kunkler, UK

Medical Oncology in early breast cancer

Expert:

Laura Biganzoli, IT

Medical Oncology in advanced breast cancer

Expert:

Etienne Brain, FR

Side effects in older patients: differences in incidence and management

Expert:

Nicolò Matteo Luca Battisti, UK

Q&A and conclusions

Experts:	Riccardo A. Audisio, IT - Nicolò Matteo Luca Battisti, UK - Etienne Brain, FR - Ian Kunkler, UK
Chairs:	Laura Biganzoli, IT - Olivia Pagani, CH